Donanemab for down syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 4 Apr 2025: Trial registered, NCT06911944

The trials

NCT06911944: Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

State
Not started
Phase
Phase 4
People
60 planned
Started
1 Aug 2026
Primary completion
31 Dec 2028
Arms
donanemab
Results
None posted
  1. 4 Apr 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.